CA Stock MarketDetailed Quotes
APLI Appili Therapeutics Inc
- 0.040
- +0.005+14.29%
15min DelayMarket Closed Nov 26 16:00 ET
4.85MMarket Cap-1333P/E (TTM)
0.040High0.035Low19.00KVolume0.040Open0.035Pre Close715.00Turnover0.06052wk High0.02%Turnover Ratio121.27MShares0.02552wk Low-0.03EPS TTM4.27MFloat Cap1.890Historical HighLossP/E (Static)106.83MShs Float0.025Historical Low-0.03EPS LYR14.29%Amplitude--Dividend TTM-0.39P/B1Lot Size--Div YieldTTM
About Appili Therapeutics Inc Company
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.
Company Profile
SymbolAPLI
Company NameAppili Therapeutics Inc
Founded2015
MarketTSE
Employees7
Fiscal Year Ends03-31
Address1344 Summer Street Suite 21
CityHalifax
CountryCAN
Zip CodeB3H 0A8
Phone+1 902 442-4655
Company Executives
- Name
- Position
- Salary
- Dr. Don Cilla, M.B.A.
- President, Chief Executive Officer and Director
- --
- Dr. Gary Nabors, PhD
- Chief Development Officer
- --
- Kenneth G. Howling
- Acting Chief Financial Officer
- --
- Dr. Armand Balboni, M.D.,PhD
- Chairman of the Board
- --
- Arthur Baran
- Director, New Product Development
- --
- Dr. Carl Gelhaus, PhD
- Director, Non Clinical Research
- --
- Brian Bloom
- Independent Director
- --
- Prakash Gowd
- Independent Director
- --
- Dr. Theresa Matkovits, PhD
- Lead Independent Director
- --
- Dr. Juergen Kurt Froehlich
- Independent Director
- --
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data